Pages that link to "Q34057610"
Jump to navigation
Jump to search
The following pages link to Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis (Q34057610):
Displaying 50 items.
- Toxic epidermal necrolysis and Stevens-Johnson syndrome (Q21202877) (← links)
- The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation (Q21284983) (← links)
- Muscle relaxants for non-specific low-back pain (Q24247746) (← links)
- Use of steroids for erythema multiforme in children (Q24548286) (← links)
- HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol (Q24555784) (← links)
- Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components (Q24616291) (← links)
- Risk of serious skin disorders among users of oral antifungals: a population-based study (Q24803817) (← links)
- Drug induced exfoliative dermatitis: state of the art (Q26739886) (← links)
- Pharmacogenomics for personalized pain medicine (Q26765791) (← links)
- Review of Toxic Epidermal Necrolysis (Q28074097) (← links)
- Severe Cutaneous Adverse Reactions: The Pharmacogenomics from Research to Clinical Implementation (Q28076600) (← links)
- Acetylsalicylic acid and other salicylates in relation to Stevens-Johnson syndrome and toxic epidermal necrolysis (Q28180571) (← links)
- Toxic epidermal necrolysis caused by tetrazepam (Q28237514) (← links)
- Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classes (Q28243911) (← links)
- Investigations of interactions of chlormezanone racemate and its enantiomers on human keratinocytes and human leucoytes in vitro (Q28251142) (← links)
- Medical genetics: a marker for Stevens-Johnson syndrome (Q28254047) (← links)
- Low-dose diclofenac, naproxen, and ibuprofen cohort study (Q28369596) (← links)
- Cytotoxic proteins and therapeutic targets in severe cutaneous adverse reactions (Q28395744) (← links)
- Large-scale elucidation of drug response pathways in humans (Q28480519) (← links)
- Stevens-johnson syndrome associated with drugs and vaccines in children: a case-control study (Q28534684) (← links)
- Multi-indication carbamazepine and the risk of severe cutaneous adverse drug reactions in Korean elderly patients: a Korean health insurance data-based study (Q28538150) (← links)
- The Absence of CYP3A5*3 Is a Protective Factor to Anticonvulsants Hypersensitivity Reactions: A Case-Control Study in Brazilian Subjects (Q28547386) (← links)
- Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Q28554512) (← links)
- Keeping an eye on decellularized corneas: a review of methods, characterization and applications (Q30436828) (← links)
- Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry (Q31033074) (← links)
- Difficult gout and new approaches for control of hyperuricemia in the allopurinol-allergic patient (Q31935359) (← links)
- Efficacy and safety of desensitization to allopurinol following cutaneous reactions (Q32045067) (← links)
- Erythema multiforme associated with phenytoin and cranial radiation therapy: a report of three patients and review of the literature (Q33196224) (← links)
- Safety of long-term lamotrigine in epilepsy (Q33502405) (← links)
- Increased risk of erythema multiforme major with combination anticonvulsant and radiation therapies (Q33536015) (← links)
- Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy (Q33542037) (← links)
- Antimicrobial prophylaxis (Q33543761) (← links)
- Real-world efficiency of pharmacogenetic screening for carbamazepine-induced severe cutaneous adverse reactions (Q33578364) (← links)
- Toxic epidermal necrolysis following treatment of pseudotumour cerebri: a case report (Q33587297) (← links)
- Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and Treatment With a Biologic: A Case Report (Q33658630) (← links)
- Lamotrigine-associated rash: risk/benefit considerations in adults and children (Q33685953) (← links)
- Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome (Q33758106) (← links)
- Characterization of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study (Q33758581) (← links)
- HLA-A*24:02 as a common risk factor for antiepileptic drug-induced cutaneous adverse reactions (Q33788588) (← links)
- A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole. (Q33879666) (← links)
- Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions (Q33928992) (← links)
- Should celecoxib be contraindicated in patients who are allergic to sulfonamides? Revisiting the meaning of 'sulfa' allergy (Q33944895) (← links)
- Toxic epidermal necrolysis. (Q34004199) (← links)
- Hypersensitivity to pyrazolones (Q34036262) (← links)
- La nécrolyse épidermique toxique (Q34047691) (← links)
- Stevens-Johnson syndrome-toxic epidermal necrolysis (SJS-TEN) overlap associated with carbamazepine use. (Q34052496) (← links)
- Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study (Q34065974) (← links)
- Epidemiological assessment of drug-induced disease (Q34079945) (← links)
- Antiepileptic drugs toxicity: A case of toxic epidermal necrolysis in patient with phenytoin prophylaxis post-cranial radiation for brain metastases (Q34080421) (← links)
- Idiosyncratic drug reactions: the reactive metabolite syndromes (Q34081284) (← links)